Morgan Stanley maintained an Overweight rating on Sana Biotechnology, Inc. (SANA) on March 13, 2026. The firm called…
ANALYST COVERAGE
Dollar General stock fell on Friday alongside mixed analyst coverage following the company’s latest earnings report.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
Cantor Fitzgerald on March 12, 2026 maintained an Overweight rating on Agios Pharmaceuticals, Inc. (AGIO). The headline AGIO…
Cantor Fitzgerald on March 12, 2026 maintained an Overweight stance on Compass Therapeutics, Inc. (CMPX), the headline CMPX…
Recently, Freedom Capital Markets initiated coverage of Rush Street Interactive with a Buy rating, following quarterly results that…
Benchmark maintained a Buy rating on Rivian Automotive, Inc. (RIVN) on March 12, 2026 following the company’s R2…
Analyst Ratings (USA) Today’s 408 U.S. analyst ratings show a mix of cautious optimism and selective buying opportunities…
Wolfe Research maintained an Outperform rating on Celcuity Inc (CELC) on March 12, 2026 at 09:58 AM, keeping…
Analyst Ratings (USA) Today’s 408 U.S. analyst ratings show a mix of cautious optimism and selective buying opportunities…
UBS maintained its Buy rating on Cintas Corporation (CTAS) on March 12, 2026. This CTAS analyst rating comes…
On March 12, 2026, Leerink Partners and William Blair each maintained an Outperform rating on Tenaya Therapeutics, Inc.…